Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

63 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-29

Study Completion Date

2017-05-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine a) if the implementation of belatacept patient alert card (PAC) resulted in effective understanding of key safety messages and b) if the degree of understanding of key safety messages is associated with improved clinical and safety outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study

NCT01471223

Kidney Transplantation

COMPLETED

Observation Study for Prediction of Allograft Survival and Impact of Imaging in Kidney Transplant Recipients.

NCT03764124

Kidney Transplantation

RECRUITING

Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients

NCT05632523

Renal Transplant Conversion

COMPLETED

Patterns of Use of Belatacept: Analysis of Data From the Collaborative Transplant Study

NCT01476943

Transplantation, Organ

COMPLETED

HLA Eplet Mismatches to Predict Long-term Kidney Transplant Outcomes

NCT07269275

Kidney Transplant Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

3 sub studies: 2 Cross-Sectional and 1 retrospective chart review

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Transplant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients survey

Adult patients treated with belatacept for renal transplantation

No interventions assigned to this group

HCP survey

HCP with at least 1 patient taking belatacept

No interventions assigned to this group

Retrospective chart review study

Adult patients treated with belatacept for renal transplantation

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient survey (cohort 1):
* Patients has taken belatacept within the previous 3 months for renal transplantation
* Patient is over 18 years of age
* HCP survey (cohort 2):
* Physician or nurses working in nephrology centers, with at least 1 patient taking belatacept in the previous 6 months for renal transplantation (by prescribing, administering or by follow up)
* Retrospective chart review study (cohort 3):
* Patient survey questionnaire received, Informed Consent Form (ICF) signed (if required)

Exclusion Criteria

* Patient survey:
* Patient has participated in a clinical trial for their renal condition in the previous 12 months
* Currently an employee of BMS
* HCP survey:
* Physicians or nurse who have recruited patients for the Patient survey
* Currently an employee of BMS

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No